# EDGAR Filing Document

**Accession Number:** 0001837493
**File Stem:** 0001185185-26-001629
**Filing Date:** 2026-4
**Character Count:** 11446
**Document Hash:** ed5b97d71c264340e09a2692156829b8
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001185185-26-001629.hdr.sgml**: 20260430

**ACCESSION NUMBER**: 0001185185-26-001629

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20260430

**FILED AS OF DATE**: 20260430

**DATE AS OF CHANGE**: 20260430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Inspira Technologies OXY B.H.N. Ltd
- **CENTRAL INDEX KEY:** 0001837493
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L3
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40303
- **FILM NUMBER:** 26920161

**BUSINESS ADDRESS:**
- **STREET 1:** HATIDHAR 2
- **STREET 2:** 11TH FLOOR
- **CITY:** RA'ANANA
- **STATE:** L3
- **ZIP:** 4366504
- **BUSINESS PHONE:** 972-9-9664488

**MAIL ADDRESS:**
- **STREET 1:** HATIDHAR 2
- **STREET 2:** 11TH FLOOR
- **CITY:** RA'ANANA
- **STATE:** L3
- **ZIP:** 4366504

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 6-K**

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13a-16 OR 15d-16**

**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

**For the Month of April 2026 (Report No. 9)**

**Commission File Number: 001-40303**

**Inspira Technologies Oxy B.H.N. Ltd.**

**(Translation of registrant's name into English)**

**2 Ha-Tidhar St.**

**Ra'anana 4366504, Israel**

**(Address of principal executive office)**

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

**<u>CONTENTS</u>**

On April 30, 2026, Inspira Technologies Oxy B.H.N. Ltd. (the "Company") issued a press release titled "Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems," a copy of which is furnished as Exhibit 99.1 with this Report of Foreign Private Issuer on Form 6-K (this "Report").

The first four and the seventh paragraphs, as well as the section titled "Forward-Looking Statement Disclaimer," of the press release are incorporated by reference into the Company's Registration Statements on Form F-3 (Registration Nos. [333-284308](https://www.sec.gov/Archives/edgar/data/1837493/000121390025004023/ea0227763-f3_inspira.htm) and [333-289324](https://www.sec.gov/Archives/edgar/data/1837493/000121390025072618/ea0251967-f3_inspira.htm)) and Form S-8 (Registration Nos. [333-259057](https://www.sec.gov/Archives/edgar/data/1837493/000121390021044780/ea146415-s8_inspiratech.htm), [333-277980](https://www.sec.gov/Archives/edgar/data/1837493/000121390024023044/ea0201791-s8_inspira.htm), [333-285565](https://www.sec.gov/Archives/edgar/data/1837493/000121390025020699/ea0233153-s8_inspira.htm), [333-290162](https://www.sec.gov/Archives/edgar/data/1837493/000121390025086563/ea0254938-s8_inspira.htm) and [333-292592](https://www.sec.gov/Archives/edgar/data/1837493/000121390026001862/ea0272007-s8_inspira.htm)), filed with the Securities and Exchange Commission, to be a part thereof from the date on which this Report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

---

| | |
|:---|:---|
| **Exhibit No.** | |
| 99.1 | [Press Release issued by Inspira Technologies Oxy B.H.N. Ltd. on April 30, 2026, titled "Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems."](iinnex99-1.htm) |

---

**<u>SIGNATURES</u>**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **Inspira Technologies Oxy B.H.N. Ltd.** | **Inspira Technologies Oxy B.H.N. Ltd.** | **Inspira Technologies Oxy B.H.N. Ltd.** |
| Date: April 30, 2026 | By: | /s/ Dagi Ben-Noon | /s/ Dagi Ben-Noon |
|  |  | Name: | Dagi Ben-Noon |
|  |  | Title: | Chief Executive Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

**Inspira and Qarakal Sign Joint Development Agreement for Cryogenic Interconnects in Superconducting Quantum Systems**

RA'ANANA, Israel, April 30, 2026 — Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN**)** ("Inspira" or the "Company") today announced the entry into a Joint Development Agreement (the "Agreement") with Qarakal Quantum Ltd. ("Qarakal Quantum" or "Qarakal"), a full-stack quantum computing company developing superconducting quantum computers. The collaboration brings Inspira's Additively Manufactured Electronics (AME) platform, which operates under the brand name QTREX, into a working superconducting quantum environment to address one of the field's most persistent scaling challenges: high-performance signal connectivity in cryogenic environments.

The Agreement establishes a structured, multi-phase engineering program to test and evaluate Inspira's technology under quantum-relevant cryogenic conditions. Qarakal Quantum will provide the technical requirements for the program, after which the parties will finalize a joint development plan with agreed success metrics, testing scope, timelines, and resource commitments.

Under the joint development plan, Inspira will provide Qarakal Quantum with 3D-printed conductive and insulating structures designed to test high-density routing, integrated transitions, embedded shielding concepts, monolithic rigid-flex structures, and more compact interconnect geometries within constrained cryogenic volumes. Qarakal Quantum will test and integrate these structures at milli-Kelvin temperatures in its cryogenic development environment and provide engineering feedback.

Qarakal's technology reflects a convergence of advanced academic research, intellectual property and hands-on engineering execution. Qarakal focuses on the design and fabrication of superconducting quantum processors, along with the development of novel quantum gates and circuits aimed at addressing complex computational challenges beyond the practical reach of classical systems.

"This Agreement places Inspira's technology in a real-world quantum development environment, where its performance can be evaluated under relevant cryogenic conditions," said Dagi Ben-Noon, Chief Executive Officer of Inspira. "This is a structured technical collaboration built around to be agreed upon defined metrics, direct cryogenic testing, and engineering feedback. This is how real value is built in quantum infrastructure- through measurable execution against one of the field's most important scaling challenges."

Dr. Nissan Maskil, Chief Executive Officer of Qarakal Quantum, added: "At Qarakal, our mission is to move quantum computing beyond monolithic lab machines toward modular, deployable, and scalable quantum infrastructure. A critical bottleneck in this evolution is the cabling density and thermal efficiency required to manage scaling signal connectivity within the dilution refrigerator."

This collaboration marks a concrete step in Inspira's strategic expansion into quantum computing and reinforces the Company's focus on addressing one of the field's most important infrastructure bottlenecks: high-performance connectivity within cryogenic environments for superconducting systems.

**About Inspira Technologies**

Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) is a technology company focused on solving the most critical physical and hardware bottlenecks in quantum computing connectivity. Inspira develops unique quantum connectivity solutions designed for high-density, thermally optimized operation in dilution cryostats, a prerequisite for scaling quantum systems beyond current physical limitations. Additionally, the Company continues to advance its medical technology portfolio, including its respiratory support and blood monitoring platforms under a dedicated business unit. For more information, please visit: www.q-trex.com and www.inspira-technologies.com

**About Qarakal Quantum**

Qarakal Quantum is a quantum computing company building modular, deployable superconducting quantum systems designed for real-world scale. By combining application-specific quantum chips, full-stack co-design, and a patented modular architecture, Qarakal enables quantum computers that can be upgraded, expanded, and adapted for operational use—moving the industry beyond monolithic lab machines toward scalable quantum infrastructure. The company was co-founded by its CEO, Dr. Nissan Maskil, who brings deep systems engineering and defense-industry leadership experience, and its CTO, Prof. Nadav Katz of the Hebrew University of Jerusalem, a leading physicist in superconducting quantum systems. For further information, please visit: https://qarakal.ai/

**Forward-Looking Statement Disclaimer**

This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the expected outcomes and benefits of the Agreement with Qarakal Quantum, including the ability to successfully develop, test and evaluate its cryogenic interconnect technologies under quantum-relevant conditions, , the potential performance and scalability of its solutions in cryogenic environments, the expected value of engineering feedback and performance data obtained through the collaboration, the ability of the Company's technology to address key connectivity challenges in quantum computing infrastructure, the Company's strategic expansion to quantum computing, Qarakal's mission to move quantum computing beyond monolithic lab machines toward modular, deployable, and scalable quantum infrastructure and the potential for such collaborations to support the Company's broader strategic expansion into the quantum computing market and development of future commercial opportunities. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website at www.sec.gov.

**Company Contact**<br> Inspira Technologies<br> Email: info@inspirao2.com<br> Phone: +972-9-9664485

**Investor Relations Contact**<br> Arx Investor Relations<br> North American Equities Desk<br> inspira@arxhq.com